Ilex Medical (ILX) — Net Asset Quality Index
Ilex Medical (ILX) has a Net Asset Quality Index of 69.7% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ILA947.26 Million minus total liabilities of ILA286.90 Million yields net assets of ILA660.36 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check ILX financial resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Ilex Medical Net Asset Quality Index Over Time (2008–2024)
This chart shows how Ilex Medical's Net Asset Quality Index has evolved across 17 annual periods from 2008 to 2024. As of June 2025, the index stands at 69.7%, representing net assets of ILA660.36 Million against total assets of ILA947.26 Million ILA. See Ilex Medical (ILX) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Ilex Medical (2008–2024)
The table below presents the year-by-year Net Asset Quality Index for Ilex Medical from 2008 to 2024, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of Ilex Medical.
| Year | Quality Index | Net Assets (ILA) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 65.0% | ILA646.49 Million | ILA994.07 Million | ILA347.58 Million | ▲ +3.7 pp |
| 2023 | 61.4% | ILA623.51 Million | ILA1.02 Billion | ILA392.61 Million | ▼ -6.8 pp |
| 2022 | 68.2% | ILA613.10 Million | ILA899.18 Million | ILA286.08 Million | ▲ +2.4 pp |
| 2021 | 65.8% | ILA575.57 Million | ILA875.07 Million | ILA299.49 Million | ▲ +8.9 pp |
| 2020 | 56.9% | ILA443.54 Million | ILA779.25 Million | ILA335.71 Million | ▲ +1.3 pp |
| 2019 | 55.6% | ILA323.48 Million | ILA581.85 Million | ILA258.38 Million | ▲ +0.6 pp |
| 2018 | 55.0% | ILA293.49 Million | ILA533.38 Million | ILA239.89 Million | ▲ +0.1 pp |
| 2017 | 54.9% | ILA266.15 Million | ILA484.92 Million | ILA218.77 Million | ▲ +4.7 pp |
| 2016 | 50.2% | ILA244.51 Million | ILA487.56 Million | ILA243.05 Million | ▲ +3.2 pp |
| 2015 | 46.9% | ILA225.99 Million | ILA481.60 Million | ILA255.61 Million | ▲ +6.5 pp |
| 2014 | 40.4% | ILA204.60 Million | ILA506.54 Million | ILA301.94 Million | ▲ +0.3 pp |
| 2013 | 40.1% | ILA214.38 Million | ILA534.54 Million | ILA320.16 Million | ▼ -3.2 pp |
| 2012 | 43.3% | ILA259.96 Million | ILA600.69 Million | ILA340.74 Million | ▲ +2.1 pp |
| 2011 | 41.2% | ILA282.99 Million | ILA687.23 Million | ILA404.25 Million | ▼ -21.9 pp |
| 2010 | 63.0% | ILA120.80 Million | ILA191.62 Million | ILA70.82 Million | ▼ -3.0 pp |
| 2009 | 66.0% | ILA127.32 Million | ILA192.91 Million | ILA65.60 Million | ▲ +1.7 pp |
| 2008 | 64.3% | ILA109.44 Million | ILA170.14 Million | ILA60.69 Million | — |